4.53
price up icon9.69%   0.40
after-market Handel nachbörslich: 4.55 0.02 +0.44%
loading

Sellas Life Sciences Group Inc Aktie (SLS) Neueste Nachrichten

pulisher
02:03 AM

SELLAS Life Sciences Group Stock Jumps 9.5% - National Today

02:03 AM
pulisher
Apr 05, 2026

Stock Report: Will SELLAS Life Sciences Group Inc benefit from green energy policies2026 Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 04, 2026

FRA:RXK3 PB Ratio: 9.04 — 66% Above Median - GuruFocus

Apr 04, 2026
pulisher
Apr 03, 2026

SELLAS Life Sciences Group (SLS) price target increased by 26.83% to 8.84 - MSN

Apr 03, 2026
pulisher
Apr 03, 2026

Sellas Life Sciences draws significant retail buzz as traders eye REGAL phase 3 catalyst – SLS stock soars 15% - MSN

Apr 03, 2026
pulisher
Apr 03, 2026

SLS stock rallies ahead of AML trial readout — 'Pharma Bro' Martin Shkreli says he's still 'very bearish,' predicts drug will fail - MSN

Apr 03, 2026
pulisher
Apr 03, 2026

SELLAS Life Sciences (SLS) to present SLS009 data at AACR 2026 - MSN

Apr 03, 2026
pulisher
Apr 02, 2026

SLS Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026
pulisher
Mar 30, 2026

SELLAS Life Sciences Group Stock Price Drops 7.7% - National Today

Mar 30, 2026
pulisher
Mar 30, 2026

Gainers Report: Whats next for SELLAS Life Sciences Group Inc stock2026 Highlights & Low Risk Growth Stock Ideas - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 7.7%Here's Why - MarketBeat

Mar 30, 2026
pulisher
Mar 30, 2026

SLS Forecast, Price Target & Analyst Ratings | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - ChartMill

Mar 30, 2026
pulisher
Mar 29, 2026

Why SELLAS Life Sciences Group (SLS) Is Down 8.3% After US$150 Million ATM Offering News - simplywall.st

Mar 29, 2026
pulisher
Mar 29, 2026

SLS stock jumps overnight: ‘potent’ AML drug data ahead of cancer summit fuels fresh momentum - MSN

Mar 29, 2026
pulisher
Mar 28, 2026

Sellas Life Sciences Secures Shelf Registration to Bolster Financial Flexibility - timothysykes.com

Mar 28, 2026
pulisher
Mar 28, 2026

Wall Street Analysts Believe SELLAS Life Sciences Group, Inc. (SLS) Could Rally 63.58%: Here's is How to Trade - MSN

Mar 28, 2026
pulisher
Mar 28, 2026

A Look At SELLAS Life Sciences Group (SLS) Valuation After SLS009 Data And New Equity Offering Plans - simplywall.st

Mar 28, 2026
pulisher
Mar 27, 2026

SELLAS Life Sciences (SLS) to Present SLS009 Data at AACR 2026 - Insider Monkey

Mar 27, 2026
pulisher
Mar 27, 2026

MACD Signal: Is SELLAS Life Sciences Group Incs ROIC above industry average2026 Price Targets & Smart Investment Allocation Tips - baoquankhu1.vn

Mar 27, 2026
pulisher
Mar 27, 2026

Vanguard (SLS) files amendment showing 0% beneficial ownership (warrants disclosed) - Stock Titan

Mar 27, 2026
pulisher
Mar 26, 2026

5 Popular Penny Stocks on Robinhood to Buy - Insider Monkey

Mar 26, 2026
pulisher
Mar 26, 2026

All you need to know about SELLAS Life Sciences Group, Inc. (SLS) rating upgrade to buy - MSN

Mar 26, 2026
pulisher
Mar 26, 2026

All Essential Information Regarding SELLAS Life Sciences Group, Inc. (SLS) Rating Raised to Buy - Bitget

Mar 26, 2026
pulisher
Mar 26, 2026

All You Need to Know About SELLAS Life Sciences Group, Inc. (SLS) Rating Upgrade to Buy - Yahoo Finance

Mar 26, 2026
pulisher
Mar 25, 2026

SELLAS Life Sciences Group Inc (SLS) Stock News & Articles - 24/7 Wall St.

Mar 25, 2026
pulisher
Mar 25, 2026

SLS Stock Jumps After Merck's Tern Deal Sparks Buyout Buzz In Blood-Cancer Space: Retail Bets On This Big Pharma Suitor - Stocktwits

Mar 25, 2026
pulisher
Mar 24, 2026

SLS Eyes New Capital Streams with Securities Shelf Registration - StocksToTrade

Mar 24, 2026
pulisher
Mar 24, 2026

SELLAS Life Sciences Group (NASDAQ:SLS) Trading Down 8.5%Here's Why - MarketBeat

Mar 24, 2026
pulisher
Mar 24, 2026

SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths - AOL.com

Mar 24, 2026
pulisher
Mar 23, 2026

Sellas Life Sciences: New Price Targets Signal Optimism Amid Clinical Progress - stockstotrade.com

Mar 23, 2026
pulisher
Mar 23, 2026

SELLAS Life Sciences Group (NASDAQ:SLS) Trading Up 12.9%Here's Why - MarketBeat

Mar 23, 2026
pulisher
Mar 23, 2026

Dagco Inc. Purchases Shares of 577,540 SELLAS Life Sciences Group, Inc. $SLS - marketbeat.com

Mar 23, 2026
pulisher
Mar 22, 2026

SELLAS Life Sciences Group, Inc.(NasdaqCM:SLS) added to S&P Biotechnology Select Industry Index - marketscreener.com

Mar 22, 2026
pulisher
Mar 22, 2026

Penny Stocks To ResearchMarch 22nd - MarketBeat

Mar 22, 2026
pulisher
Mar 22, 2026

Assessing SELLAS Life Sciences Group (SLS) Valuation After Its Sharp Recent Share Price Run - Yahoo Finance

Mar 22, 2026
pulisher
Mar 21, 2026

Penny Stocks To Watch NowMarch 21st - MarketBeat

Mar 21, 2026
pulisher
Mar 21, 2026

BUY Rating on SELLAS: Pivotal REGAL Phase 3 Progress, Expanding AML Pipeline, and Cash Runway into 2027 Support Upside Potential - TipRanks

Mar 21, 2026
pulisher
Mar 21, 2026

Investment Review: Whats the beta of SELLAS Life Sciences Group Inc stockMarket Performance Recap & High Return Trade Opportunity Guides - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 21, 2026

SELLAS Life Sciences’ AML Pipeline Adds Key Clinical Checkpoints For Investors - simplywall.st

Mar 21, 2026
pulisher
Mar 20, 2026

SELLAS Life Sciences Group, Inc.: Fundamental Analysis and Financial Ratings | | US81642T2096 - marketscreener.com

Mar 20, 2026
pulisher
Mar 20, 2026

Form S-3ASR Sellas Life Sciences Group Inc For: 20 March - Investing.com

Mar 20, 2026
pulisher
Mar 20, 2026

SELLAS (NASDAQ: SLS) registers shelf and $150M ATM with TD Cowen - Stock Titan

Mar 20, 2026
pulisher
Mar 20, 2026

SLS Stock In Focus As Alliance Global Sees 92% Upside Following AML Trial Updates - Stocktwits

Mar 20, 2026
pulisher
Mar 20, 2026

SELLAS Life Sciences Group (NASDAQ:SLS) Shares Gap Up on Earnings Beat - MarketBeat

Mar 20, 2026
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):